Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of FBT's 31 holdings also in CANC
22.2%
% of CANC's 46 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 3.4% | 5.6% | 3.4% |
|
ILLUMINA INC | 3.2% | 3.5% | 3.2% |
|
EXACT SCIENCES CORP | 2.9% | 3.1% | 2.9% |
 |
ARGENX SE ADR | 3.3% | 2.9% | 2.9% |
|
GILEAD SCIENCES INC | 3.4% | 2.9% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to CANC
|
INTRA-CELLULAR THERAPIES INC | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
AMGEN INC | 3.5% |
 |
BIONTECH SE SPONSORED ADR | 3.5% |
|
HALOZYME THERAPEUTICS INC | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
CATALYST PHARMACEUTICAL PART | 3.4% |
|
ACADIA PHARMACEUTICALS INC | 3.4% |
|
BIOGEN IDEC INC | 3.4% |
|
NEUROCRINE BIOSCIENCES INC | 3.4% |
FBT Underweight Relative to CANC
|
MERCK & CO. INC. | -5.6% |
 |
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
 |
NOVARTIS AG | -3.7% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |
|
CELLDEX THERAPEUTICS INC | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.4% |